01—History
EPS (Diluted) History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $2.36
1 older move runs past ±150% (largest +184.5%); point at, tap or drag across the bars to read one.
02—Ledger
EPS (Diluted), period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $2.36 | −1.3% | 10-K | |
| FY2024 | $2.39 | −12.1% | 10-K | |
| FY2023 | $2.72 | −59.0% | 10-K | |
| FY2022 | $6.63 | +2.8% | 10-K | |
| FY2021 | $6.45 | +137.1% | 10-K | |
| FY2020 | $2.72 | −48.5% | 10-K | |
| FY2019 | $5.28 | +44.3% | 10-K | |
| FY2018 | $3.66 | +10.9% | 10-K | |
| FY2017 | $3.30 | −9.1% | 10-K | |
| FY2016 | $3.63 | +16.0% | 10-K | |
| FY2015 | $3.13 | +184.5% | 10-K | |
| FY2014 | $1.10 | −57.0% | 10-K | |
| FY2013 | $2.56 | −23.6% | 10-K | |
| FY2012 | $3.35 | +53.7% | 10-K | |
| FY2011 | $2.18 | — | 10-K |
03—Questions
What is eps (diluted)?
Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.
What is AbbVie Inc.'s current eps (diluted)?
AbbVie Inc. (ABBV) annual eps (diluted) for 2025 was $2.36, a 1.26% decline from 2024. AbbVie Inc. eps (diluted) for the quarter ending March 31, 2026 was $0.39.
What was AbbVie Inc.'s eps (diluted) in 2024?
AbbVie Inc. annual eps (diluted) for 2024 was $2.39, a 12.13% decline from 2023.
What was AbbVie Inc.'s eps (diluted) in 2023?
AbbVie Inc. annual eps (diluted) for 2023 was $2.72, a 58.97% decline from 2022.
What is AbbVie Inc.'s 5-year eps (diluted) CAGR?
AbbVie Inc. eps (diluted) grew at a compound annual growth rate (CAGR) of 2.80% from FY2020 to FY2025, going from $2.72 to $2.36 over 5 years.
- Company
- AbbVie Inc.
- Ticker
- ABBV
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations